20 Facts You Should Know About Immunotherapy Treatment

FACT #3:Immunotherapy treatment was named ASCO's "Advance of the Year" each of the last two years.

Immunotherapy has received high recognition from the American Society of Clinical Oncology (ASCO). In February, they named it the "Advance of the Year" once again. This groundbreaking treatment is proving its worth, offering long-term benefits to various cancer patients. In 2017 alone, eight immunotherapies gained approval, including durvalumab and avelumab, marking significant progress in the field. These achievements owe much to the dedicated work of Cancer Research Institute (CRI) scientists over decades.

Dr. Lloyd J. Old, often hailed as the "Father of Modern Tumor Immunology," played a pivotal role in advancing immunotherapy. He led CRI's scientific and medical endeavors for four decades, from 1971 to 2011. During this time, Dr. Old made critical discoveries about the connection between the immune system and cancer, laying the groundwork for the development of today's successful immunotherapies.